期刊文献+

肝细胞肝癌重要表面标志的表达和定位 被引量:10

Expression and location of some important cell surface biomarkers in hepatocellular carcinoma
下载PDF
导出
摘要 目的肝细胞肝癌(hepatocellular carcinoma,HCC)是我国常见恶性肿瘤。作为其主要标志分子的甲胎蛋白(α-fetoprotein,AFP)表达具有一定局限性,临床需要联合其他标志分子以提高诊断准确性。文中旨在探讨若干候选生物标志物在中国人源HCC细胞和正常肝细胞中的表达和定位。方法采用直接或间接免疫荧光染色方法,探讨角蛋白(cytokeratin,CK)、去唾液酸糖蛋白受体1(asialoglycoprotein receptor1,ASGR1)和ASGR2、细胞表面分子(GPC3、CD90、CD133和EpCAM)等7种主要HCC表面标志分子在Bel-7402、Bel-7404和SMMC-7721等人HCC及正常肝细胞HL-7702的表达与定位情况。结果 CK、ASGR1和ASGR2在所有的肝来源细胞均表达;GPC3仅在HCC细胞表达。CD90、CD133和EpCAM仅在少量肝肿瘤干细胞(liver cancer stem cells,LCSCs)表达。结论 CK、ASGR1和ASGR2为肝细胞标志,GPC3是HCC相关标志;CD90、CD133和EpCAM仅在极少数肝肿瘤干细胞表达。 Objective Hepatocellnlar carcinoma (HCC) is one of the most common malignant tumors with a high incidence rate in China. Alpha-fetaprotein (AFP) has some limitations in the diagnosis of HCC, so its combination with other hiomarkers could improve the diagnostic accuracy. The aim of this study is to explore the expression and location of some candidate biomarkers in Chi- nese HCC cell lines and normal hepatocytes. Methods Using direct or indirect immunofluorescent staining, we studied the expressions and locations of the candidate biomarkers CK, ASGRt, ASGR2, GPC3, CD90, CD133 and EpCAM in Bel-7402, Bel-7404, SMMC-7721 in human HCC and HL-7702 in normal hepatocytes. Results CK, ASGR1 and ASGR2 were detected in all the cell lines, while GPC3 merely in HCC cells. CD90, CD133 and EpCAM were expressed in only a few of liver cancer stem cells. Conclusion CK, ASGR1 and ASGR2 are common biomarkers of hepatocytes, while GPC3 is an HCC-related biomarker. CD90, CD133 and EpCAM are expressed in a small fraction of liver cancer stem cells.
出处 《医学研究生学报》 CAS 北大核心 2013年第1期4-8,共5页 Journal of Medical Postgraduates
基金 "十二五"国家科技重大专项(2012ZX10002-017) 国家自然科学基金(81071789)
关键词 肝细胞肝癌 生物标志 免疫荧光 肿瘤干细胞 Hepatocellular carcinoma Biomarker Immunofluorescence Cancer stem cell
  • 相关文献

参考文献30

  • 1El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma[J]. Gastroenterology, 2012, 142(6): 1264-1273.
  • 2Chen M, Therneau T, Orsini LS, et al. Design and rationale of the HCC BRIDGE study in China: a longitudinal, multicenter cohort trial in hepatocellular carcinoma[J]. BMC Gastroenterol, 2011, 11: 53.
  • 3Hsu HC, Cheng W, Lai PL. Cloning and expression of a developmentally regulated transcript MXR7 in hepatocellular carcinoma: biological significance and temporospatial distribution[J]. Cancer Res, 1997, 57(22): 5179-5184.
  • 4Chen DS, Sung JL. Serum alphafetoprotein in hepatocellular carcinoma[J]. Cancer, 1977, 40(2): 779-783.
  • 5Trevisani F, D′Intino PE, Morselli-Labate AM, et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status[J]. J Hepatol, 2001, 34(4): 570-575.
  • 6Karantza V. Keratins in health and cancer: more than mere epithelial cell markers[J]. Oncogene, 2011, 30(2): 127-138.
  • 7D′Errico A, Baccarini P, Fiorentino M, et al. Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA detection[J]. Hum Pathol, 1996, 27(6): 599-604.
  • 8Yang XR, Xu Y, Shi GM et al. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection[J]. Clin Cancer Res, 2008, 14(12): 3850-3859.
  • 9Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms[J]. Histopathology, 2002, 40(5): 403-439.
  • 10Spiess M, Lodish HF. Sequence of a second human asialoglycoprotein receptor: conservation of two receptor genes during evolution[J]. Proc Natl Acad Sci USA, 1985, 82(19): 6465-6469.

二级参考文献2

共引文献66

同被引文献155

  • 1王庆浩,陈爱华,张伯礼.丹参:一种中药研究的模式生物[J].中医药学报,2009,37(4):1-3. 被引量:38
  • 2贺轶锋,樊嘉,周俭,吴志全,邱双健,黄晓武,余耀,孙健,肖永胜,杨国欢,宋康,王征,汤钊猷,王玉琦.影响肝癌肝移植预后的高危因素分析及诊治经验[J].中华医学杂志,2006,86(18):1232-1235. 被引量:27
  • 3刘道永,孙冰生,武金才,李国才,任宁,高冬梅,钦伦秀.应用滤过富集法检测肝癌患者外周血中肿瘤细胞[J].中华实验外科杂志,2007,24(4):498-499. 被引量:6
  • 4Khachigian LM, Santiago FS, Rafty LA, et al. GC factor 2 re- presses platelet-derived growth factor A-chain gene transcription and is itself induced by arterial injury [ J ]. Circ Res, 1999, 84 (11) : 1258-1267.
  • 5Ohtsuka H, Oikawa M, Ariake K, et al. GC-binding factor 2 in- teracts with dishevelled and regulates Wnt signaling pathways in human carcinoma cell lines [ J]. Int J Cancer, 2011, 129 (7) : 1599-1610.
  • 6Dai P, Jeong SY, Yu Y, et al. Modulation of TLR signaling by multiple MyD88-interacting partners including leucine-rich repeat Fli-I-interacting proteins [ J ] J Immunology, 2009, 182 ( 6 ) : 3450-3460.
  • 7Rikiyama T, Curtis J, Oikawa M, et al. GCF2: expression and molecular analysis of repression [ J ]. Biochim Biophys Acta, 2003, 1629(1-3): 15-25.
  • 8Stenner-Liewen F, Luo G, Sahin U, et al. Definition of tumor-as- sociated antigens in hepatocellular carcinoma [ J ]. Cancer Epide- miol Biomarkers Prey, 2000, 9 (3) : 285-290.
  • 9Ariake K, Ohtsuka H, Motoi F, et al. GCF2/LRRFIP1 promotes colorectal cancer metastasis and liver invasion through integrin-de- pendent RhoA activation [J]. Cancer Lett, 2012, 325 ( 1 ) : 99-107.
  • 10Zhang S, Liu X, Zhang Y, et al. RNAi screening identifies KAT8 as a key molecule important for cancer cell survival[ J]. Int J Clin Exp Pathol, 2013, 6(5) : 870-877.

引证文献10

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部